Contact person: Mr. Julin Julin
Position: china
Address: Shanghai
Country: China
Phone: 15021762752 - Mobi: 15021762752
Intermittent Hypoxic Hyperoxic Device
Price: 1
https://www.rejuve-lab.com/intermittent-hypoxic-hyperoxic-treatment.html
Intermittent Hypoxic Hyperoxic Treatment Device
Rlab's Intermittent Hypoxic Hyperoxic Training Device, also known as IHHT or the cell trainer, represents a cutting-edge solution in intelligent intermittent hypoxic hyperoxic training. By integrating advanced monitoring and precise gas delivery, this device provides users with a safe and effective means to enhance their physical health and overall well-being.
Intermittent Hypoxic Hyperoxic Treatment Overview
Intermittent Hypoxia-Hyperoxia Therapy (IHHT) is an innovative and safe approach that has demonstrated effectiveness in improving energy levels and reducing disease risk. IHHT is particularly effective in improving symptoms and functionality across a wide spectrum of health conditions, including cardiovascular, respiratory, musculoskeletal, neurological, and metabolic pathologies. It is also promising for elderly patients with multiple comorbidities, underscoring its comprehensive impact on health and well-being.
Mechanism of IHHT
IHHT involves breathing varying concentrations of oxygen through a mask, which promotes the regeneration of healthier mitochondria by eliminating damaged ones. Mitochondria, vital for energy production, can become damaged under stress. IHHT introduces mild respiratory stress that triggers a natural cellular "fine-tuning" response, enhancing cellular interactions between the environment and the body and potentially improving quality of life.
Scientific Recognition
The significance of IHHT was highlighted by the 2019 Nobel Prize in Physiology or Medicine, awarded to three scientists for their work on the mechanism of Hypoxia-Inducible Factor 1 (HIF-1). Their research elucidated how aerobic organisms adapt to changes in oxygen levels, influencing more than 1,000 genes downstream, including those that enhance erythropoiesis and the adaptability of respiratory and cardiovascular systems to hypoxic conditions.
Rlab's Technological Integration
Rlab's Intermittent Hypoxic Hyperoxic Training Device is based on the physiological adaptations of the human body at high altitudes and exercise science theories. This device offers a range of models, allowing users to select the one that best suits their needs. The product employs intelligent algorithms and real-time monitoring through blood oxygen saturation sensors and heart rate sensors to intermittently and precisely deliver mixed gases with different oxygen concentrations (9-34%). This process aims to improve physical function, burn fat, and shape the body more safely and comfortably.
Intermittent Hypoxic Hyperoxic Treatment Device
Rlab's Intermittent Hypoxic Hyperoxic Training Device, also known as IHHT or the cell trainer, represents a cutting-edge solution in intelligent intermittent hypoxic hyperoxic training. By integrating advanced monitoring and precise gas delivery, this device provides users with a safe and effective means to enhance their physical health and overall well-being.
Intermittent Hypoxic Hyperoxic Treatment Overview
Intermittent Hypoxia-Hyperoxia Therapy (IHHT) is an innovative and safe approach that has demonstrated effectiveness in improving energy levels and reducing disease risk. IHHT is particularly effective in improving symptoms and functionality across a wide spectrum of health conditions, including cardiovascular, respiratory, musculoskeletal, neurological, and metabolic pathologies. It is also promising for elderly patients with multiple comorbidities, underscoring its comprehensive impact on health and well-being.
Mechanism of IHHT
IHHT involves breathing varying concentrations of oxygen through a mask, which promotes the regeneration of healthier mitochondria by eliminating damaged ones. Mitochondria, vital for energy production, can become damaged under stress. IHHT introduces mild respiratory stress that triggers a natural cellular "fine-tuning" response, enhancing cellular interactions between the environment and the body and potentially improving quality of life.
Scientific Recognition
The significance of IHHT was highlighted by the 2019 Nobel Prize in Physiology or Medicine, awarded to three scientists for their work on the mechanism of Hypoxia-Inducible Factor 1 (HIF-1). Their research elucidated how aerobic organisms adapt to changes in oxygen levels, influencing more than 1,000 genes downstream, including those that enhance erythropoiesis and the adaptability of respiratory and cardiovascular systems to hypoxic conditions.
Rlab's Technological Integration
Rlab's Intermittent Hypoxic Hyperoxic Training Device is based on the physiological adaptations of the human body at high altitudes and exercise science theories. This device offers a range of models, allowing users to select the one that best suits their needs. The product employs intelligent algorithms and real-time monitoring through blood oxygen saturation sensors and heart rate sensors to intermittently and precisely deliver mixed gases with different oxygen concentrations (9-34%). This process aims to improve physical function, burn fat, and shape the body more safely and comfortably.
SEND INQUIRY
Please fill in fully your information to send email
CATEGORY
Agriculture